*:Co-first author; #:Co-corresponding author
1.Yang W*, Zhang C*, Liu LB*, Bian ZZ*, Chang JT, Fan DY, Gao N#, Wang PG#, An J#. Immunocompetent mouse models revealed that S100A4+ monocytes/macrophages facilitate long-term Zika virus infection in the testes. Emerg Microbes Infect. 2024 Dec;13(1):2300466. doi: 10.1080/22221751.2023.2300466.
2.Liu LB*, Li M*, Gao N*, Shen JY, Sheng ZY, Fan DY, Zhou HN, Yin XX, Mao JR, Jiang JY#, Wang PG#, An J#. Epidemiological and clinical characteristics of the chikungunya outbreak in Ruili City, Yunnan Province, China. J Med Virol. 2022 Feb;94(2):499-506. doi: 10.1002/jmv.27302.
3.Wang R, Fan D, Wang L, Li Y, Zhou H, Gao N, An J. Seroprevalence of Dengue Virus among Young Adults in Beijing, China, 2019. Virol Sin. 2021 Apr;36(2):333-336. doi: 10.1007/s12250-020-00285-4.
4.Wang R, Fan D, Wang L, Li Y, Zhou H, Gao N, An J. Neutralizing antibody rather than cellular immune response is maintained for nearly 20 years among Japanese encephalitis SA14-14-2 vaccinees in an endemic setting. Infect Genet Evol. 2020 Nov;85:104476. doi: 10.1016/j.meegid.2020.104476.
5.Fan D*, Wu N, Zhang J, Wang Z, Wang P, Gao N#, An J. Effect of the Rho GTPase inhibitor-1 on the entry of dengue serotype 2 virus into EAhy926 cells. Mol Biol Rep. 2020 Dec;47(12):9739-9747. doi: 10.1007/s11033-020-05980-9.
6.Gao N*, Li J*, Sheng Z, Chen H, Fan D, Wang P, An J. Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice. Appl Microbiol Biotechnol. 2019 Jun;103(12):4977-4986. doi: 10.1007/s00253-019-09798-9.
7.Li J*, Gao N*, Fan D, Chen H, Sheng Z, Fu S, Liang G#, An J#. Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice. Sci Rep. 2016 Jan 28;6:19953. doi: 10.1038/srep19953.